Heads up for ESPR on the NASDAQ. Released news after market close on Friday that their drug label has been expanded to include all patients with hypercholesteremia. This is what statins are used for. Now Nexletol can be used without statins, i.e. in place of statins. Statins are one of the biggest pharmaceutical money-makers with 70M patients in the US alone.
